Accueil / Tag Archives: Clinical Trials

Tag Archives: Clinical Trials

InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at New Jersey’s Cooper Neurological Institute

Monday, March 20th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord …

Plus »

Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy

Monday, March 20th 2017 at 2:00pm UTC First study of a liquid biopsy to predict response to immunotherapy Highly accurate with a PPV of 92% and 100% for progression after one and two cycles respectively Early discovery of treatment-induced hyper-progressive disease Published in the peer-reviewed journal, Clinical Cancer Research SAN …

Plus »

Novaliq GmbH Announces Licensing Agreement with AFT Pharmaceuticals for the Distribution of NovaTears®

Monday, March 20th 2017 at 7:45pm UTC NovaTears®, A Novel Treatment for Dry Eye Disease, Is Now Available in Australia and New Zealand HEIDELBERG, Germany–(BUSINESS WIRE)– Novaliq, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced a …

Plus »

ERYTECH présente de nouvelles données précliniques anti-tumorales avec erymethionase lors de l’AACR 2017

Monday, March 20th 2017 at 5:40pm UTC LYON, France–(BUSINESS WIRE)– Regulatory News: ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY), société biopharmaceutique de stade clinique développant à partir de sa plateforme propriétaire d’encapsulation de médicaments dans les globules rouges des thérapies innovantes contre des formes rares de cancers et des maladies orphelines, annonce aujourd’hui …

Plus »

Knopp Biosciences annonce l’élection à son conseil de gestion de Shane Kovacs, dirigeant de Biotech

Tuesday, March 21st 2017 at 12:38pm UTC PITTSBURGH–(BUSINESS WIRE)– Knopp Biosciences LLC a annoncé aujourd’hui la nomination de Shane Kovacs à son conseil de gestion, avec effet immédiat. M. Kovacs, un ancien banquier d’investissement dans le secteur des sciences de la vie, est vice-président exécutif et directeur financier de PTC …

Plus »

Poxel Announces Positive Results for Thorough QT Safety Clinical Study of Imeglimin

Tuesday, March 21st 2017 at 7:00am UTC LYON, France–(BUSINESS WIRE)– POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for type 2 diabetes, today announced that it has successfully completed a thorough QT/QTc (TQT) cardiac safety study on Imeglimin in 55 healthy …

Plus »

Cerulean and Daré to Host Conference Call on Proposed Transaction on March 23

Tuesday, March 21st 2017 at 1:38am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Cerulean Pharma Inc. (NASDAQ:CERU), today announced jointly with Daré Bioscience that the companies will hold a joint conference call to discuss the definitive share purchase agreement under which the stockholders of Daré Bioscience will become the majority owners of Cerulean. …

Plus »

AstraZeneca’s CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Hospitalizations for Heart Failure and Death versus Other Type-2 Diabetes Medicines

Sunday, March 19th 2017 at 6:05pm UTC Landmark real-world evidence from an international study of more than 300,000 patients with type-2 diabetes showed treatment with SGLT-2 inhibitors reduced risk of hospitalization for heart failure by 39% and all-cause mortality by 51% CVD-REAL data are presented at the American College of …

Plus »

Syros Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Monday, March 20th 2017 at 12:01pm UTC – Presented Data at Key Medical Meetings Further Supporting Therapeutic Potential of SY-1425 in Genomically Defined AML, MDS and Breast Cancer Patients – – Highlighted Data at Scientific Conferences Demonstrating Productivity of Syros’ Gene Control Platform in Oncology and Immuno-oncology – – On …

Plus »

Siamab Therapeutics to Present New Preclinical Data for Its Novel Antibodies and Antibody Drug Candidates at the American Association for Cancer Research Annual Meeting 2017

Tuesday, March 21st 2017 at 12:01pm UTC NEWTON, Mass.–(BUSINESS WIRE)– Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced it will present preclinical data for its novel anti-Sialyl-Tn (STn) and anti-CD3 bispecific antibodies and antibody drug candidates (ADCs) during two poster presentations at the American Association for …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...